Nucleic Acid Sample Preparation Market Size is valued at USD 2.89 Billion in 2023 and is predicted to reach USD 4.57 Billion by the year 2031 at a 6.10% CAGR during the forecast period for 2024-2031.
Molecular biology relies on nucleic acid sample preparation to extract, purify, and concentrate DNA or RNA from blood, tissue, cell, and environmental samples. High-quality nucleic acids are essential for genetic and molecular analysis like PCR, NGS, cloning, and gene expression research. This rigorous technique isolates them. Automated nucleic acid extraction systems and pre-packaged reagent kits are now widely used, enabling researchers to process multiple samples simultaneously with minimal variation between runs.
Specialized kits designed for specific sample types or downstream applications facilitate more adaptable and streamlined workflows, addressing the varied requirements of genetic research and clinical diagnostics. The progress made in nucleic acid sample preparation technologies has greatly facilitated the speed of molecular biology research, enabling significant breakthroughs and practical applications in genetics, medicine, and biotechnology.
Furthermore, the present COVID-19 pandemic has highlighted the urgent need for accurate and timely testing, which mostly relies on the efficient processing of nucleic acid samples. In addition, given the growing prevalence of genetic disorders and the expanding applications of nucleic acid sample preparation in personalized medicine and diagnostics, the market is anticipated to continue expanding. Furthermore, the high cost of complex kits deters smaller research institutes from utilizing them, which is another limitation of the global nucleic acid sample preparation market.
Competitive Landscape
Some Major Key Players In The Nucleic Acid Sample Preparation Market:
- Merck KGaA
- BGI Group (MGI Tech Co., Ltd.)
- Hoffmann-La Roche Ltd
- Agilent Technologies, Inc.,
- Danaher (Beckman Coulter, Inc.)
- Eppendorf SE
- Bioneer Corporation
- Norgen Biotek Corp
- Aurora Biomed Inc.
- Becton, Dickinson and Company,
- Bio-Rad Laboratories Inc.,
- DiaSorin S.p.A,
- Miroculus, Inc.,
- Illumina, Inc.,
- PerkinElmer, Inc.,
- QIAGEN,
- Sigma Aldrich Corp.,
- Tecan Group AG,
- Thermo Fisher Scientific, Inc
- Other Prominent Players
Market Segmentation:
The nucleic acid sample preparation market is segmented on the basis of product, technology, source type, application, and end-user. The product category comprises Consumables (which includes Kits (DNA/RNA Sample Isolation/Extraction/Purification, DNA/RNA Clean-Up and Concentration, and DNA and RNA Quantification), Reagents), and Instruments. According to the technology segment, the market includes Silica-Based, Magnetic Particle Technology, and Other Technologies. By application, the market is segmented into PCR, qPCR, NGS, Cloning, Microarray, Blotting Techniques, and Other Applications. According to the end-users, the market is categorized as Academic Research Institutes and Laboratories, Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Clinical Diagnostic Centers, and Applied Testing (Forensic, Biobanks).
As Per The Product Segment, The Consumables Segment Is A Major Contributor To The Nucleic Acid Sample Preparation Market.
The consumables category is expected to hold a major share of the global nucleic acid sample preparation market in 2022. Improvements in consumables that result in the introduction of new goods and a rise in analytical techniques are predicted to propel the nucleic acid sample preparation market's growth. These advances should accelerate the usage of kits such as those for protein and nucleic acid extraction, purification, and isolation, as well as the frequent production of samples using plates and tubes. There will be a greater demand for kits across various applications because they also provide consistency in sample preparation.
The Pharmaceutical & Biotechnology Companies Segment Is Expected To Witness Rapid Growth.
The pharmaceutical & biotechnology companies category is projected to grow rapidly in the global nucleic acid sample preparation market. This segment's significant market share in nucleic acid sample preparation is explained by the high amount of money spent on pharmaceutical R&D, the pressure on pharmaceutical companies to launch new treatments, and the trend toward process automation and integration among businesses, which has resulted in the use of integrated and automated workstations for sample preparation.
In The Region, The North American Nucleic Acid Sample Preparation Market Holds A Significant Revenue Share.
The North American nucleic acid sample preparation market is expected to record a large market revenue share in the near future. This is because the market for nucleic acid sample preparation is growing due to a number of variables, such as the increased frequency of genetic disorders, significant investments in the life sciences, and a robust infrastructure for research. Prominent biotechnology and pharmaceutical businesses are present, and the industry is growing because of encouraging government initiatives. In addition, Asia Pacific is estimated to grow at a rapid rate in the global nucleic acid sample preparation market. The market is expanding due to the growing focus on genetics in nations like China and India, increased research efforts, and changing healthcare infrastructure. The growing consumer interest in genetic research and molecular diagnostics is driving the growth of the nucleic acid sample preparation market in this industry.
Recent Developments
- November 2023, The TissueLyser III and RNeasy PowerMax Soil Pro Kit, introduced by QIAGEN, were specifically engineered to optimize RNA isolation and sample processing. TissueLyser III improved the QIAGEN portfolio for the production of high-throughput samples. Compatibility with the TissueLyser III, the RNeasy PowerMax Soil Pro Kit employed sophisticated Inhibitor Removal Technology to process difficult soil samples as part of a streamlined workflow.
- In Dec 2023, Thermo Fisher Scientific unveiled novel sample preparation tools that streamline and automate respiratory diagnostic testing. The introduction of the new Thermo Scientific KingFisher Apex Dx system and Applied Biosystems MagMAX Dx Isolation Kit has enhanced the preanalytical procedures in clinical laboratories.
Nucleic Acid Sample Preparation Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 2.89 Bn |
|
Revenue Forecast In 2031 |
USD 4.57 Bn |
|
Growth Rate CAGR |
CAGR of 6.10 % from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product, Technology, Source Type, Application, And End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
BGI Group (MGI Tech Co., Ltd.), Danaher (Beckman Coulter, Inc.), Eppendorf SE, Bioneer Corporation, F. Hoffmann-La Roche Ltd, Norgen Biotek Corp, Aurora Biomed Inc., Merck KGaA, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., DiaSorin S.p.A, Miroculus, Inc., Illumina, Inc., PerkinElmer, Inc., QIAGEN, Sigma Aldrich Corp., Tecan Group AG, and Thermo Fisher Scientific, Inc. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
